Atlas Trials

Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer

Clinical trial NCT00006022 · COMPLETED

Trial details

NCT number
NCT00006022
Sponsor
Virginia Commonwealth University
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Kidney CancerMelanoma (Skin)
Start date
2000-09-01
Primary completion
2003-10-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.